Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity inhepatocellular carcinoma cells through downregulating twist-mediated CD10expression. | Environ Toxicol | 2018 Jun | 29480568 |
The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibitinghomeodomain-interacting protein kinase 2 expression. | Kidney Int | 2017 Sep | 28318631 |
Spatial distribution of pesticide use in Brazil: a strategy for HealthSurveillance. | Cien Saude Colet | 2017 Oct | 29069184 |
Anti-inflammatory, antimycobacterial and genotoxic evaluation of Doliocarpusdentatus. | J Ethnopharmacol | 2017 May 23 | 28392458 |
Structure-Activity Relationship of Niclosamide Derivatives. | Anticancer Res | 2017 Jun | 28551619 |
Niclosamide as an anti-obesity drug: an experimental study. | Eat Weight Disord | 2017 Jun | 28271456 |
Repurposing niclosamide as a versatile antimicrobial surface coating againstdevice-associated, hospital-acquired bacterial infections. | Biomed Mater | 2017 Jul 12 | 28471351 |
Role of nutraceutical SIRT1 modulators in AMPK and mTOR pathway: Evidence of asynergistic effect. | Nutrition | 2017 Feb | 28063518 |
Existing drugs as broad-spectrum and potent inhibitors for Zika virus bytargeting NS2B-NS3 interaction. | Cell Res | 2017 Aug | 28685770 |
Identification of small-molecule inhibitors of Zika virus infection and inducedneural cell death via a drug repurposing screen. | Nat Med | 2016 Oct | 27571349 |